Biomarkers of high-grade serous ovarian carcinomas
Patent
·
OSTI ID:1532021
The present disclosure provides biomarkers useful for determining the prognosis of conditions such as ovarian cancer. The presently disclosed subject matter provides angiogenic biomarkers and methods and compositions for predicting overall survival (OS) in women with high-grade serous carcinomas (HGSCs). The presently disclosed subject matter provides compositions and methods that enable rationally directed therapies to improve outcome in women with HGSC.
- Research Organization:
- Duke Univ., Durham, NC (United States)
- Sponsoring Organization:
- USDOE
- Assignee:
- Duke University (Durham, NC)
- Patent Number(s):
- 9,771,620
- Application Number:
- 14/282,603
- OSTI ID:
- 1532021
- Resource Relation:
- Patent File Date: 2014-05-20
- Country of Publication:
- United States
- Language:
- English
Similar Records
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
Genome Wide DNA Copy Number Analysis of Serous Type Ovarian Carcinomas Identifies Genetic Markers Predictive of Clinical Outcome
Association between CT-texture-derived tumor heterogeneity, outcomes, and BRCA mutation status in patients with high-grade serous ovarian cancer
Journal Article
·
Fri Jul 01 00:00:00 EDT 2016
· Cell
·
OSTI ID:1532021
+44 more
Genome Wide DNA Copy Number Analysis of Serous Type Ovarian Carcinomas Identifies Genetic Markers Predictive of Clinical Outcome
Journal Article
·
Wed Feb 15 00:00:00 EST 2012
· PLoS ONE
·
OSTI ID:1532021
+14 more
Association between CT-texture-derived tumor heterogeneity, outcomes, and BRCA mutation status in patients with high-grade serous ovarian cancer
Journal Article
·
Sat Jun 15 00:00:00 EDT 2019
· Abdominal Radiology (Online)
·
OSTI ID:1532021
+7 more